CURRICULUM VITAE



CURRICULUM VITAE

GUSTAVO DANIEL LOPARDO, MD

April 2016

name: Gustavo Daniel Lopardo

present title: Staff member FUNCEI. Buenos Aires, Argentina.

Staff member of the department of infectious Hospital Bernardo Houssay, Vicente López, Buenos Aires, Argentina.

address: Figueroa Alcorta 3044 10th D (1425) - Buenos Aires,

Argentina.

Mobile phone 15 4403 5708

E-mail: glopardo@

office address: French 3085. (1425) - Buenos Aires, Argentina

citizenship: Argentine

birthdate: December 12th, 1961

EDUCATION

March, 1975 through Colegio Nacional de Adrogué

December, 1979 "Almirante G. Brown"

Buenos Aires, Argentina

Grade point average: 9.04 (scale of 0-10)

March, 1981 through Universidad de Buenos Aires

December, 1986 Facultad de Medicina (Medical School)

Degree: Medical Doctor

Grade point average: 8.90 (scale of 0-10)

postgraduate training

May 2, 1987 through Residency in Internal Medicine

April 30, 1990 Department of Internal Medicine

Sanatorio Güemes-Hospital Privado. Buenos Aires, Argentina.

Elective Rotations:

May, 1989 through Department of Infectious Diseases and

July, 1989 Preventive Medicine

Sanatorio Güemes-Hospital Privado. Buenos Aires, Argentina

August, 1989 through Department of Hematology

October, 1989 Hospital de Clínicas "José de San Martín".

Buenos Aires, Argentina

October, 1989 through Department of Internal Medicine

December, 1989 Clínica Modelo Morón. Buenos Aires, Argentina

May 2, 1990 through Fellowship in Infectious Diseases.

April 30, 1992, Department of Infectious Disease and Preventive Medicine.

Sanatorio Güemes-Hospital Privado. Buenos Aires, Argentina

Elective Rotations:

September 12-20, 1992 Department of Special Immunology. Jackson Memorial Hospital. University of Miami. Miami, FLA. USA.

Sept. 22, 1992 through Department of Infectious Diseases. MD Anderson Cancer October 26, 1992 Center. Houston, TX. USA

March 2001-July 2001. Training in Research Methodology. Academia Nacional

de ……………………………………………Medicina.

“Curso de formación de investigadores clínicos. Prof. Dr. José Tessler”. Duración 145 horas. GEDIC, Grupo de Estudio, Docencia e Investigación Clínica. 2003.

academic appointments

October, 1983 through Teaching Assistant

February, 1987 Department of Physiology

Universidad de Buenos Aires, Medical School

April, 1993 through Teaching Assistant

May 2006 Department of Medicine, Infectious Diseases

Teaching Unit of Hospital Durand

Universidad de Buenos Aires, Medical School

May 2006 through Assistant professor, Infectious Diseases

present date Universidad de Buenos Aires, Medical School

1998 Board Certified as Infectious Diseases Specialist, by Academia Nacional de Medicina

2008 Recertified Infectious Diseases, by Academia Nacional de Medicina

languages

Proficiency in English

Cambridge Institute of English Culture

Advanced courses

Buenos Aires, Argentina

Proficiency in French

Alianza Francesa de Buenos Aires

Intermediate Courses

Buenos Aires, Argentina

honors and awards

December, 1986 Diploma of Honor

Universidad de Buenos Aires, Medical School

May 2006 Best abstract about HIV infection, titled: Lopardo G, Bissio E, Crespo

A, Garone D, Bugaría G. No se hallaron alteraciones en el

funcionamiento neurocognitivo de pacientes VIH reactivos con

inmunidad conservada, ni tampoco diferencias entre pacientes con

inmunidad conservada recibiendo HAART o naive de tratamiento.

Abstract 190. VI Congreso Argentino SADI. May 5-6, 2006, Mar del

Plata, Argentina

May 2008 Award Espinola L, Lopardo G, Niccodemi MC, Guzzi L, Poggi E,

Lijavetzky A, Barcelona L, Luna C, Rodríguez E, Corral J, Peyrani P,

Ramírez J. Mortalidad en pacientes con neumonía provenientes de

geriátrico: estudio caso-control. VIII Congreso de la Sociedad

Argentina de Infectología. Mar del Plata May 22-24 2008. Oral

session. Abstract 22894

April 2009 Third pice: Lopardo G, Guzzi L, Niccodemi MC, Peyrani P, Ramirez

J. Severity of desease and non-streptococcus pneumoniae bacteriemia

in hospitalized patients with community-acquired pneumonia: result

from the CAPO international cohort study. XIV Congreso de la

Asociación Panamericana de infectología. Campos do Jordao. April

25-28, 2009.

May 2011 Third pice: Lopardo, G; Bissio, E; Peyrani, P; Ramirez, J; Grupo CAPO. The use of macrolides was associated with lower mortality in patients with bacteremic pneumonia. XI Congreso de la Sociedad Argentina de Infectología, Mar del Plata 19 y 20 de mayo de 2011. Abstract 29129

June 2013 Segundo Premio: Monczor A, Confalonieri V, Monserrat M, Copertari G, Fernandez Mozun F, Tempelsman R, Lopardo G. Durabilidad de los esquemas de tratamiento antiretroviral Mar del Plata 9-1 de junio de 2013. 20129.

PROFESSIONAL EXPERIENCE

May 1990 through Emergency Room Staff

December 1996 Centro Integral Médico (CIM). Buenos Aires, Argentina

May 1992 through Outpatient Parenteral Antibiotic Therapy Program Coordinator.

2002 Centro de Estudios Infectológicos.

(CEI). Buenos Aires, Argentina

May, 1992 through Staff Member. Department of Infectious Diseases

July 1998 Instituto de las Clínicas Cardiovasculares.

Buenos Aires, Argentina

May 1992- June 1993 Sanatorio Güemes-Hospital Privado

Medical Staff, Department of Infectious

Diseases. Buenos Aires, Argentina

May 1992 through Staff member FUNCEI, Buenos Aires, Argentina

Present date

June 1995 through Staff member. Department of Infectious Diseases

April 2004 Clínica La Sagrada Familia, Buenos Aires, Argentina

2003 through present date Staff member of the department of Infectious diseases, Hospital Prof. Dr. Bernardo Houssay, Hospital Municipal de Vicente López

SCIENTIFIC AFFILIATIONS:

1992 through Panamerican Society of Infectious Diseases

present date Member

1996 through Sociedad Argentina de Infectología

Currently President of the Argentinian Society of Infectious Diseases

1996 through Sociedad Argentina de Microbiología

present date Member

1998 through International AIDS Society (IAS)

present date Member

April 2007 through Coordinator of the Argentinean chapter of APUA (Alliance

2008 for the prudent use of antibiotics)

International Society of Infectious Diseases (ISID)

Member

PUBLICATIONS

a. abstracts:

Stamboulian D, Lopardo G. Infections associated with renal transplantation. Our experience during the period from 1/90 through 12/91. 2do. Congreso de la Sociedad Argentina de Infectología. Buenos Aires. April 26-29, 1992.

Lepetic A, Rosenthal V, Altclas J, Lopardo G, Finquelievich J, Stamboulian D. Infections in renal transplant recipients in the late period. Our experience between 1/90-12/91. 2do. Congreso de la Sociedad Argentina de Infectología. Buenos Aires, April 26-29, 1992.

Argüello E, Lopardo G, Mar’n M, Absis D, Stamboulian D. Purulent mediastinitis post cardiovascular surgery. International Congress for Infectious Diseases. Nairobi, Kenya. June 7-11, 1992.

Argüello E, Bermejo J, Lopardo G, Absi D, Stamboulian D. Purulent mediastinitis after cardiac surgery. Prospective study of 231 cases: 1979-92. VI Congreso Panamericano de Infectolog’a. X Congreso Chileno de Infectología. Vi–a del Mar, Chile. May 26-29, 1993.

Lopardo G, Stamboulian D. Outpatient treatment of severe infectious diseases. II Simposio Internacional de Infectolog’a Pediátrica. I Congreso Interamericano de Infectología. Jornadas Franco Argentinas de Infectología. Córdoba, May 8-11, 1994.

Lopardo G, Carbone E, Pensotti C, Cassetti I, Stamboulian D. Establishing an outpatient parental antibiotic therapy program in Argentina. Outpatient Intravenous Infusion Therapy Association (OPIVITA) III Annual Education Conference. Chicago, IL. April 21-22, 1995.

Lopardo G, Cassetti I, Vujacich C, Stamboulian D. Seroprevalence of Hepatitis B and C, toxoplasmosis and VDRL in HIV positive patients seen in an ambulatory center. VII Congreso Panamericano de Infectología. Cartagena de Indias, Colombia. May 28-31, 1995. (Abstract C-25.247).

Cassetti I, Lopardo G, Vujacich C, Batalla V, Stamboulian D. Relationship between the CD4 cell count and development of oportunistic infections in HIV positive individuals. II Congreso Argentino de SIDA, Córdoba. October 26-29, 1995. (Abstract PA8-110).

Bonvehi P, Lopardo G, Falco A, Temporiti E, Relloso S, Cassetti L, Ruttimann R, Herrera F, Smayevsky J, Stamboulian D. Candidemia in adult HIV positive patients: a report of five cases without risk factor for candidemia. XI International Conference on AIDS. Vancouver, Canada. July 7-12, 1996.. (Abstract We.B.3219).

Belloso W, Marchetti M, Lopardo G y col. Long term efficacy of low dose intermittent cotrimoxazole for Pneumocistis carinii prophilaxis in AIDS patients. XI Conference on AIDS. Vancouver, Canada. July 7-12, 1996.(Abstract Pub.B.1031).

Lopardo G, Sturba E, Roel J y col. Incidence of infections due to Mycoplasma pneumoniae, Chlamydia spp y Legionella pneumophila in a group of patients with community adquired pneumonia. I Congreso de infectología y microbiologia clínica (SADI-SADEBAC). Buenos Aires, July 15-18,1997. (Abstract D327)

Nacinovich F, Lopardo G, Stamboulian D. Outpatient parenteral antibiotic therapy in the elderly. I Congreso de infectología y microbiología clínica (SADI-SADEBAC). Buenos Aires, July 15-18,1997. (Abstract K328).

Lopardo G, Stamboulian D, Cassetti L. Polirradiculomielopatia asociada a Citomegalovirus en un paciente con SIDA. III Congreso Argentino de SIDA. Mar del Plata, November 27-30,1997.

Belloso W., Lopardo G., Tessler J, Stern L.D., Rodríguez V., Vasen W., Etchegoyen M.. Quality of life assessment in patients with HIV infection in Argentina. 12th World AIDS Conference Geneve. June28-July 3, 1998. (Abstract 14341).

Lopardo G, Belloso W, Quiros R, Bottaro E, Barcan L, Ivalo S, Lazovski J. Factors associated with hipercholesterolemia (HC) and hipertriglyceridemia (HT) in HIV positive patients. 36th Annual Meeting of the Infectious Diseases Society of America (IDSA), Denver, Co, USA. November 12-15, 1998. (Abstract 480).

Losso M, Belloso WH, Benetucci JA, Cahn PE, Lasala MC, Lopardo G, Salomon H, Saracco M, S. Emery, Allende MC, Law MG, Davey RT, , Lane C. Evaluation of subcutaneous interleukin-2 plus antiretroviral therapy vs. antiretrovirals alone in patients with HIV-1 infection and CD4+ cell count (350/mm3. 6th Conference on Retrovirus and Opportunistic Infections. Chicago, IL, USA. January 31-February 4, 1999. (Abstract 354).

Podesta O, Romero R, Llambias P, Galdon F, Scilingo V, Marin M, Lopardo G, Stamboulian D. Estudio prospectivo para la detección de pacientes colonizados con enterococo resistente a la vancomicina (ERV) en una unidad de cuidados intensivos. IX Congreso Panamericano de Infectología. API 1999. Ciudad de Guatemala, Guatemala, May 3-7, 1999.

Losso M, Belloso WH, Benetucci JA, Cahn PE, Lasala MC, Lopardo G, Salomon H, Saracco M, Emery J, L Fosdick, Allende MC, Davey RT, , Lane C. Vanguard Study Group. Twenty month follow up of the Argentina Vanguard study: A randomized, controlled, phase II trial of intermitent interleukin-2 (scIL2) plus antiretroviral therapy (ARV) vs. ARV alone. 7th Conference on Retrovirus and Opprtunistic Infections. San Francisco, CA, USA. January 30-February 2, 2000. (Abstract 380).

Barcelona L, Lopardo G, Debbag R, Lazovski J, Bugarin G, Stamboulian D. Developing outpatient parenteral antimicrobial therapy (OPAT) programs: the experience of an ID team in Argentina. 9th International Congress on Infectious Diseases, Buenos Aires, Argentina. April 10-13, 2000. (Abstract 44016)

Belloso W, Lopardo G, Ivalo s, Ishida S, Tessler J, Barcan L, Cassetti I, Stern L, Clara L. Lipodystrophy syndrome: predicting factors for body fat redistribution. 9th International Congress on Infectious Diseases, Buenos Aires, Argentina. April 10-13, 2000. (Abstract 78020)

Nacinovich F, Lopardo G, Daher J, Stamboulian D. Laryngeal histoplasmosis in HIV positive patients. 14th Congress of thye International Society for Human and Animal Mycology. May 8-12, 2000. Buenos Aires, Argentina.

Grazziutti M, Belloni R, Fridman D, Barcelona L, Tronge P, Lopardo G*, Stamboulian D Sepsis due to Capnocytophaga ochracea: case presentation.. Pan American Association of Infectious Diseases. X Pan American Congress, Guadalajara, Mexico. May 1-5, 2001.

Lopardo G, Goldenberg F, Perez a, Abalo S, Belloni R, Fridman D, Rodriguez Vivie H, Saenz C, Gross P, Galdon F, Stamboulian D. Eficacy of non-broncoscopic lavage for the diagnosis of ventilator associated pneumonia. Pan American Association of Infectious Diseases. X Pan American Congress, Guadalajara, Mexico. May 1-5, 2001.

Bottaro E, Laurido M, Caiafa D, Bugarin G, Pascual A, Lopardo G, Cassetti I. Switching protease inhibitors in non-failing HIV+ patients. The 1st IAS Conference on HIV pathogenesis and treatment. July 8-11, 2001, Buenos Aires, Argentina

Cassetti I, Montes J, Pascual A, Lopardo G, Bottaro E, Lazovski J, Stamboulian D. Preliminary results from the lopinavir/ritonavir early-access program. The 1st IAS Conference on HIV pathogenesis and treatment. July 8-11,2001 Buenos Aires, Argentina

Belloso W, Consiglio E, Lopardo G, Chiocconi E, Etchegoyen M, Amin M, Tessler J. Quality of life instrument development in Argentinian HIV+ population (preliminary report). The 1st IAS Conference on HIV pathogenesis and treatment. July 8-11,2001 Buenos Aires, Argentina

Bottaro E, Urquiza A, Caiafa D, Trinidad P, Lopardo G, Cassetti I. Stopping suppressive therapy for opportunistic infections: a safe strategy. XIV International AIDS Conference 2002, July 7-12, Barcelona, Spain.

Lopardo G, Fridman D, González Arzac M, Calmaggi A, Smayevsky J, Podestá O, Clara L. Infección urinaria no complicada: bajos porcentajes de resistencia a trimetoprima-sulfametoxazol en la ciudad de Buenos Aires. XI Congreso Panamericano de Infectología, Córdoba, Argentina, May 11-14, 2003.

Rodríguez Iantorno P, Elmassian P, Fridman D, Lopardo G, Podestá O, Stamboulian D. Análisis epidemiológico de las bacteriemias en una institución de la ciudad de Buenos Aires en la actualidad. XI Congreso Panamericano de Infectología, Córdoba, Argentina, May 11-14, 2003.

Sarubbi M, Vazquez L, Ortiz de Zárate M, Rodríguez C, Cañete G, Luppino V, Carranza C, Galimberti D, García F, Sturba E, Lopardo G, Stamboulian D. Perinatal HIV infection: results of a vertical transmission prevention program (AMAPES). 2nd IAS Conference on HIV pathogenesis and Treatment. Paris July 13-16, 2003.

Bottaro EG, Figueroa R, Scapellato PG, Vidal GI, Rodriguez Brieschke MT, Laurido MF, Caiafa D, Lopardo G, Herrera F, Cassetti I. Osteonecrosis en pacientes con SIDA: presentación de una serie. 6( Congreso Argentino de SIDA. Buenos Aires November 20-23, 2003.

Lopardo G, Bugarin G, Fridman D, Elmassian P, Spina Peña M, Huberman M. Seguridad de la rifampicina como parte del tratamiento de la tuberculosis en pacientes HIV reactivos con HAART. 6( Congreso Argentino de SIDA. Buenos Aires May 20-23, 2003.

Belloso WH, Consiglio E, Quirós RE, Lopardo G, Chiocconi E, Martins M, Woloski P, Sanchez M. Desarrollo de un cuestionario específico de calidad de vida para pacientes con infección por HIV (proyecto CV AR). 6( Congreso Argentino de SIDA. Buenos Aires November 20-23, 2003.

Lopardo G. Bugarin G., Fridman D., Elmassian P., Espina Peña M., Huberman M., Cassetti I., Stamboulian D. Seguridad y eficacia del tratamiento de tuberculosis con regímenes que incluyen rifampicina más terapia antirretroviral de alta eficacia. Abstract 141. IV Congreso Argentino de Infectología. Mar del Plata May 7-9, 2004

Vizzotti C., Espina Peña M., Lopardo G., Fridman D., Vazquez L., Stamboulian D. Síndrome febril prolongado: importancia de la presentación clínica inicial. Abstract 296. IV Congreso Argentino de Infectología. Mar del Plata, May 7-9, 2004.

Espina Peña M., Vizzotti C., Lopardo G., Fridman D., Vazquez L., Stamboulian D. Fiebre de origen desconocido: evaluación de 104 pacientes que consultaron en un centro de infectología ambulatorio de la ciudad de Buenos Aires. Abstract 297. IV Congreso Argentino de Infectología. Mar del Plata May 7-9, 2004.

Vizzotti C., Lopardo G., Espina Peña M., Crespo A., Fridman D., Vazquez L., Stamboulian D. Sífilis: formas de presentación en pacientes co-infectados y no co-infectados con VIH. V Congreso Argentino de Infectología. Mar del Plata May 6-8, 2005.

Petroni A., Deluchi G., Bortolizzi R., Garone D., Lopardo G., Pryluka D., Rodríguez C., Calan L., Lazaro M., Maranzana A., Puga L., Benetucci J. Update on primary HIV-1 resistance in Argentina: the first report of mutations conferring high-level resistence to non-nucluoside reverse transcripatase inhibitors (NNRTI) in drug-naïve patients. 3rd IAS Conference on HIV pathogenesis and treatment. Rio de Janeiro July 24-27, 2005

Guzzi L, Latorraca M, Bassuk A, Barcelona L, Lopardo G Meningitis por Streptococcus bovis secundaria a endocarditis infecciosa: una complicación poco frecuente. XVI Congreso Nacional de Medicina. November 21-24, 2005, Buenos Aires, Argentina

Belloso WH, Sánchez ML, Ajzenszlos MR, Otegui IM, Lopardo GD, Galich AM, Delfante A, UGT S, Rey R, Clara LO. Impacto de un programa de nutrición y ejercicio sobre parámetros de riesgo cardiovascular en pacientes con lipodistrofia (Estudio LUNES). Abstract 194. Resultados preliminares. VII Congreso Argentino de SIDA. November 24-26, 2005, La Plata, Argentina

Vizzotti C, Lopardo G, Espina Peña M, Crespo A, Fridman D, Bugarin G, Cassetti I. Sífilis: formas de presentación en pacientes co-infectados con VIH y no co-infectados. Abstract 288. Resultados preliminares. VII Congreso Argentino de SIDA. November 24-26, 2005, La Plata, Argentina

Buono M, Barcelona L, Farías A, Crivelli C, Lopardo G. Endocarditis infecciosa por Pseudomonas aeruginosa en válvula nativa no asociada a adicción I.V. Abstract 151. VI Congreso Argentino SADI. May 5-6, 2006, Mar del Plata, Argentina

Lopardo G, Fridman D, Cassetti I. Psicosis aguda inducida por efavirenz. Resumen 188. VI Congreso Argentino SADI. May 5-6, 2006, Mar del Plata, Argentina

Lopardo G, Benchetrit G, Corral J, De Vedia L, González J, Luna C, Martínez J, Marzoratti L, Rodríguez E, Rodríguez M, Victorio C, Videla A, Barcelona L, Bissio E, Peyrani P, Ramírez J. Evaluación de los índices de severidad en pacientes hospitalizados por neumonía adquirida en la comunidad en 12 centros de Argentina. Abstract 189. VI Congreso Argentino SADI. May 5-6, 2006, Mar del Plata, Argentina

Lopardo G, Benchetrit G, Corral J, De Vedia L, González J, Luna C, Martínez J, Marzoratti L, Rodríguez E, Rodríguez M, Victorio C, Videla A, Barcelona L, Bissio E, Peyrani P, Ramírez J. Agentes etiológicos de pacientes hospitalizados por neumonía adquirida en la comunidad: alta sensibilidad de los hemocultivos. Abstract 222. VI Congreso Argentino SADI. May 5-6 2006, Mar del Plata, Argentina

Lopardo G, Bissio E, Crespo A, Garone D, Bugaría G. No se hallaron alteraciones en el funcionamiento neurocognitivo de pacientes VIH reactivos con inmunidad conservada, ni tampoco diferencias entre pacientes con inmunidad conservada recibiendo HAART o naive de tratamiento. Abstract 190. VI Congreso Argentino SADI. May 5-6, 2006, Mar del Plata, Argentina

Lopardo G, Bissio E, Iannella M, Garone D, Crespo A, Cassetti I. No evidence of difference in neurological performance assessed by the International HIV dementia scale between patients with preserved immunity with and without HAART. THPE0074. XVI International AIDS Conference. August 13-18, 2006, Toronto, Canada

Belloso WH, Sánchez ML, Otegui IM, Ajzenszlos MR, Galich AM, UGT S, Lopardo G, Brites F, Delfante A, Rey R, Torres D, Clara LO. Management of Lipodystrophy trough a program of supervised Nutrition and Exercise (LUNES Study). 8th International Workshop on Adverse Drug Reactions and Lipodystrophy. San Francisco USA, Sep 24-25, 2006. Abstract 97.

Niccodemi C, Lopardo G, Guzzi L, Poggi E, Barcelona L, Garone D, Gonzalez J, Martinez J, Marzoratti L, Rodriguez E, Peyrani P, Christensen D, Ramirez J and members of CAPO Group. Diabetes mellitus no se asoció con peor pronóstico en pacientes hospitalizados por neumonía adquirida en la comunidad. VII Congreso Argentino de la Sociedad Argentina de Infectología. Mar del Plata May 4-5, 2007. Oral presentation, Abstract 17620.

Guzzi L, Lopardo G, , Poggi E, Niccodemi C, Barcelona L, Berdinas V, Benchetrit G, De Vedia L, Luna C, Peyrani P, Christensen D, Ramirez J and members of CAPO Group . Tratamiento antibiótico de pacientes hospitalizados por neumonía adquirida en la comunidad: la cobertura de gérmenes atípicos no se asoció con beneficios. VII Congreso Argentino de la Sociedad Argentina de Infectología. Mar del Plata May 4-5, 2007. Oral presentation, Abstract 17624.

Poggi E, Lopardo G, Niccodemi C, Guzzi L, Barcelona L, Corral J, Rodríguez M, Victorio C, Videla A, Peyrani P, Christensen D, Ramirez J and members of CAPO Group. Estudio comparativo de la evolución y tratamiento en pacientes hospitalizados por neumonía adquirida en la comunidad en hospitales públicos y privados. VII Congreso Argentino de la Sociedad Argentina de Infectología. Mar del Plata May 4-5, 2007. Oral presentation, Abstract 17650.

Bissio E, Lopardo G, Bugarín G. Incidencia de efectos adversos de atazanavir en la población argentina. VII Congreso Argentino de la Sociedad Argentina de Infectología. Mar del Plata May 4-5, 2007. Abstract 17539

Lopardo G, Guzzi L, Niccodemi MC, Espinola L, Lijavetzky A, Poggi E, Barcelona L, Benchetrit G, González J, Videla A, Rodríguez M, Christensen D, Peyrani P, Ramírez J y grupo CAPO. Mayor frecuencia de bacteriemia en pacientes con neumonía en Argentina en relación con otras áreas del mundo. VIII Congreso de la Sociedad Argentina de Infectología. Mar del Plata. May 22-24,2008. Oral sessionl. Abstract 22899

Niccodemi MC, Lopardo G, Lijavetzky A, Guzzi L, Poggi E, MC, Espinola L, Barcelona L, De Vedia L, Martínez J, Marzoratti L, Victorio C, Peyrani P, Ramírez J y grupo CAPO. EPOC no se asoció con mayor mortalidad en pacientes hospitalizados con neumonía adquirida en la comunidad. VIII Congreso de la Sociedad Argentina de Infectología. Mar del Plata. May 22-24,2008. Oral session. Abstract 22887

Espinola L, Lopardo G, Niccodemi MC, Guzzi L, Poggi E, Lijavetzky A, Barcelona L, Luna C, Rodríguez E, Corral J, Peyrani P, Ramírez J. Mortalidad en pacientes con neumonía provenientes de geriátrico: estudio caso-control. VIII Congreso de la Sociedad Argentina de Infectología. Mar del Plata. May22-24,2008. Oral session. Abstract 22894. Award.

A Petroni, G Delucchi, G Lopardo, I Zapiola, D Pryluka, M Lazaro, E Chiocconi, P Elmassian, H Mingrone, J Martinez, R Bertolozzi, J Benetucci. HUV resistance surveillance on recently infected drug-naive patients from Argentina. XVII International AIDS Conference. August. 3-8,2008. Mexico City Abstract TUPE0073

A. La Rosa, PR Abrao, Y Roldan, G Lopardo, O Sussman, M Castrillo, J Galindez, F Ticona, R Gutierrez, GL Italien, N Cure-Bolt, DB Pedral, Gender differences in metabolic profile and cardiovascular risk among latin American HIV infected patients on HAART. 10th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. London November 6th 2008.

O Sussman, R Salazar, J Galindez, F Rangel, ML Castañeda, G Lopardo, GA Cunha, Y Roldan, P Mantilla, GL Italien, N Cure-Bolt, M Castrillo. Prevalence and determinants of metabolic síndrome among latin american HIV infected patients on HAART. RAPID II Study. 10th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. London November 6th 2008.

Lopardo G, Guzzi L, Barcelona L, Peyrani P, Ramirez J. Severity of disease and presence of bacteriemia in hospitalized patients with community-acquired pneumonia: results from the CAPO international cohort study. XIV Congreso de la Asociación Panamericana de infectología. Campos do Jordao. April 25-28,2009.

Lopardo G, Guzzi L, Niccodemi MC, Peyrani P, Ramirez J. Severity of disease and non-streptococcus pneumoniae bacteriemia in hospitalized patients with community-acquired pneumonia: result from the CAPO international cohort study. XIV Congreso de la Asociación Panamericana de infectología. Campos do Jordao. . April 25-28,2009.

Sosa Avila L M, Barcelona L, Vieyra G, Berdiñas V, Lopardo G. Endocarditis infecciosa por C. parapsilosis asociada a marcapaso definitivo. IX Congreso de la Sociedad Argentina de Infectología, Mar del Plata. May 6-8,2009. Abstract 24718.

Lopardo G, Espinola L, Bissio E, Gallego P, Lijavetzky A, Rojas Bonilla M, Stambulian M, Gadano A. El ayuno incrementa la concentraciones séricas de bilirrubina en pacientes que reciben atazanavir. IX Congreso de la Sociedad Argentina de Infectología, Mar del Plata. May 6-8,2009. Abstract 24730.

Apesteguia A, Repetto M, De AllJ, Gnocchi C, Lopardo G, Espinola L, Olmedo G. Coinfección pulmonar por pneumocistis jirovecii y citomegalovirus em pacientes com SIDA. IX Congreso de la Sociedad Argentina de Infectología, Mar del Plata. May 6-8,2009. Abstract 24809.

Pryluka D, Lopardo G, Daciuk L, Stecher D, Bonvehí P. Hospitalizations for acute respiratory infection of health workers in the circulation of influenza A H1 N1 in Argentina. X Congreso de la Sociedad Argentina de Infectología, Mar del Plata 13 y 14 de mayo de 2010.Abstract 26634

Titanti, P; Berdiñas, V; Ramos, J; Manevich, L; Barcelona, L; Rios, P; Lopardo, G. Impact of policy restrictions as part of an antimicrobial management program at a university hospital. X Congreso de la Sociedad Argentina de Infectología, Mar del Plata 13 y 14 de mayo de 2010. Abstract 26835

Monserrat, M; Bissio, E; Lopardo, G. Severe anemia and leukopenia associated with lamivudine, a rare adverse effect. XV Congreso Panamericano de Infectología, Punta del Este 7 al 11 de abril de 2010. Abstract SP1A-004

Lopardo, G; Bissio, E; Peyrani, P; Ramirez, J; Grupo CAPO. Early initiation of antibiotics in patients with bacteremic pneumonia was associated with increased mortality. XI Congreso de la Sociedad Argentina de Infectología, Mar del Plata 19 y 20 de mayo de 2011. Abstract 29126

Lopardo, G; Bissio, E; Peyrani, P; Ramirez, J; Grupo CAPO. The use of macrolides was associated with lower mortality in patients with bacteremic pneumonia. XI Congreso de la Sociedad Argentina de Infectología, Mar del Plata 19 y 20 de mayo de 2011. Abstract 29129

Confalonieri V, Monczor A, Mozun F, Monserrat M, Tempelsman R, Copertari G, Ferraris A, Stamboulian D, Lopardo G. Reemergencia de sífilis: experiencia de un centro de la ciudad de Buenos Aires. XII Congreso de la Sociedad Argentina de Infectología, Córdoba 16 a 18 de mayo de 2012. Abstract 29781

Monserrat M, Korin J, Mattos N, Schutz N, Lopadro G. Enfermedad de Castleman multicéntrica con falla multiorgánica asociada a sarcoma de Kaposi con compromiso linfoganglionar en un paciente HIV reactivo. XII Congreso de la Sociedad Argentina de Infectología, Córdoba 16 a 18 de mayo de 2012. Abstract 29742.

Monserrat M, Bissio E, Lopardo G. Anemia, leucopenia severas asociadas a lamivudina, un efecto adverso infrecuente. XII Congreso de la Sociedad Argentina de Infectología, Córdoba 16 a 18 de mayo de 2012. Abstract 29754

Lopardo G, Guzzi L, Gentile J, Martins M, Saenz C, Fridman D, Stamboulian D. Hospitalizaciones por neumonía adquirida en la comunidad en adultos en un periodo de tres años en tres hospitales de Argentina XII Congreso de la Sociedad Argentina de Infectología, Córdoba 16 a 18 de mayo de 2012. Abstract 29800.

Copertari G, Tempelsman R Monserrat M, Monczor A, Mozun F, Confalonieri V, Ferraris A, Stamboulian D, Lopardo G. Reemergencia de sífilis: características clínicas y epidemiológicas en pacientes coinfectados con VIH y no coinfectados. XII Congreso de la Sociedad Argentina de Infectología, Córdoba 16 a 18 de mayo de 2012. Abstract 29770

Lopardo G, Fridman D, Raimondo E, Stamboulian D. Prospective population-based surveillance to determine the incidence of community-acquired pneumonia among adults, General Roca city, Río Negro, Argentina. II Conference on Controversies in Vaccination in Adults. 14 a 17 febrero 2012, Munich, Alemania.

Nacinovich F, Ruttimann R, Bonvehí P, Giglio N, Lopardo G, Stamboulian D. Burden of Community-acquired pneumonia (CAP) in Argentina. 8th International Symposium on Pneumoccici and Pneumococcal Disease. Foz do Iguazu, Brazil. 11 a 15 de marzo de 2012

Lopardo G, Noriega F, Zambrano B, Rivas E. Incidence of Clostridium difficile infections in adults at-risk hospitalized in four large centers in Latin America. XIV Congreso Panamericano de Infectología, Santiago de Chile, 28 de mayo al 1 de junio de 2013.

Lopardo G, Ortiz E; Morfin M, Moran I, Noriega F, Zambrano B, Luxemburger C, Rivas E. Incidencia de diarrhea asociada a infección por Clostridium difficile en pacientes adultos hospitalizados en cuatro centros de América Latina. XIII Congreso Argentino de Infectología, Mar del Plata, 9 al 11 de junio de 2013.

Lopardo G, Fridman D, Raimondo E, Stamboulian D. Estudio prospectivo de vigilancia epidemiológica de neumonía adquirida en la comunidad en adultos en la ciudad de General Roca, provincia de Río Negro, Argentina. XIII Congreso Argentino de Infectología, Mar del Plata, 9 al 11 de junio de 2013.

Monczor A, Confalonieri V, Monserrat M, Mozun Tamborenea F, Cisneros V, Tempelsman R, Copertari G, Ferraris A, Lopardo G. Durabilidad del primer esquema de tratamiento antirretroviral y motivos de cambio en una cohorte de personas viviendo con VIH. XIII Congreso Argentino de Infectología, Mar del Plata, 9 al 11 de junio de 2013.

Lopardo G, Fridman D, Raimondo E, Bagnulo H, Albornoz H, Goleniuk D, Sanabria M, Baez E, Stamboulian D. Preliminary results of a prospective population-based surveillance burden of community-acquired pneumonia in adults, in the South Cone of Latin-America. 9th International Symposium on Pneumoccici and Pneumococcal Disease. Hyderabad, India. 9 al 13de marzo de 2014

B. Papers

Jayaweera DT, Cassetti LI, Espinoza L; Lopardo G, Hansman-Whiteman ML, Scerpella EG. Poliradiculomielopatia causada por Citomegalovirus en pacientes con SIDA. Medicina (Buenos Aires)1998;58:135-140.

Losso M, Belloso WH, Emery S, Benetucci JA, Cahn PE, Lasala MC, Lopardo G, Salomon H, Saracco M, Nelson E, Law MG, Davey RT, Allende MC, Lane C. A randomized, controlled, phase II trial comparing escalating doses of subcutaneous interleukin-2 plus antiretrovirals versus antiretrovirals alone in human immunodeficiency virus-infected patients with CD4+ cell count (350/mm3. J Infect Dis 2000;181:1614-1621.

Gustavo Lopardo. Management of Endocarditis: Outpatient Parenteral Antibiotic Treatment in Argentina. Chemotherapy 2001;(suppl 1):24-32

Marin ME, Podesta O, Llambias P, Galdon F, Scilingo VM, Stamboulian D, Romero RH, Lopardo GD. Detection of carriage of vancomycin-reistant enterococci in an intensive care unit in Buenos Aires. Infect Control Hosp Epidemiol 2001 Jun;22(6):332-3

Lopardo G, Sturba E, Martinez ML, Roel JE, Gamba A, Biondi H, Stamboulian D. Detección de infeccion aguda por Legionella pneumophila en pacientes con Neumonía Adquirida en la Comunidad en la Ciudad de Buenos Aires. Medicina (Buenos Aires) 2002;62:145-148.

Bottaro EG, Figueroa RH, Scapellato PG, Vidal GI, Rodríguez Brieschke MT, Da Representacao S, Seoane MB, Laurido M, Caiafa D, Lopardo G, Herrera F, Cassetti I. Osteonecrosis in HIV-infected patients. Medicina (Buenos Aires) 2004;64:325-31

Consenso de Endocarditis Infecciosa. Colaborador Revista Argentina de cardiología 2002; Vol 70, Sup 5.

Petroni A, Deluchi G, Pryluka D, Rotryng F, Bortolozzi R, Lopardo G, Bouzas M, Zapiola I, Garone D, Rodríguez C, Chiocconi E, Lázaro M, Murano F, Maranzana A, Oliva S, Aparicio M, Beltrán M and. Benetucci J. Update on Primary HIV-1 Resistance in Argentina: Emergence of Mutations Conferring High-Level Resistance to Non-nucleoside Reverse Transcriptase Inhibitors in Drug-Naive Patients. J Acquir Immune Deficit Syndr 2006;42:506-510

Lopardo G, Fridman D, Gonzalez Arzac M, Calmaggi A, Smayevsky J, Podestá O, Clara L. Uropathogen resistance: are laboratory-generated data reliable enough? J Chemother 2007;19:33-7

Diana Christensen, Carlos Luna, Jorge Martinez, Eduardo Rodríguez, Lucia Marzoratti, José Gonzalez Alejandro Videla, Lautaro De Vedia, Jorge Corral, Guillermo Benchetrit, Maria Rodríguez, Carlos Victorio, Gustavo Lopardo, Paula Peyrani, Julio Ramírez. Cumplimiento con las guías nacionales en pacientes hospitalizados con neumonía adquirida en la comunidad. Medicina (Buenos Aires) 2007;67:709-713

Aliberti S, Myers JA, Peyrani P, Blasi F, Menendez R, Rossi P, Cosentini R, Lopardo G, de Vedia L,

Ramirez JÁ. The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia. Eur Respir J. 2009 Jan;33(1):142-7. Epub 2008 Oct 1.

Lopardo G, Bissio E, Iannella MC, Crespo A; Garone D, Cassetti L. Good neurocognitive performance measured by the international HIV dementia scale in early HIV-1 infection. J Acquir Immune Defic Syndr. 2009 Dec 1;52(4):488-92.

Malinis M, Myers J, Bordon J, Peyrani P, Kapoor R, Nakamatzu R, Lopardo G, Torres A, Feldman C, Allen M, Arnold F, Ramirez J. Clinical outcomes of HIV-infected patients hospitalized with bacterial community-acquired pneumonia. Int J Infect Dis. 2009 Jul 6. [Epub ahead of print]

Forest W Arnold1, DO, A. Scott LaJoie2, PhD, Paula Peyrani1, MD, Jordi Rello3, MD, Rosario Menéndez4, MD, Gustavo Lopardo5, MD, Antoni Torres6, MD, Paolo Rossi7, MD, Julio A, Ramirez1, MD and the CAPO investigators "Improving Outcomes in Elderly Patients with Community-Acquired Pneumonia by Adhering to National Guidelines", will be in the Sept 14, 2009. Arch Intern Med. 2009 Sep 14;169(16):1515-24.

INSIGHT-ESPRIT Study Group; SILCAAT Scientific Committee, Abrams D, Lévy Y, Losso MH, Babiker A, Collins G, Cooper DA, Darbyshire J, Emery S, Fox L, Gordin F, Lane HC, Lundgren JD, Mitsuyasu R, Neaton JD, Phillips A, Routy JP, Tambussi G, Wentworth D. Interleukin-2 therapy in patients with HIV infection. N Engl J Med. 2009 Oct 15;361(16):1548-59.

Aliberti S, Brock GN, Peyrani P, Blasi F, Ramirez JA; Community-Acquired Pneumonia Organization. The pneumonia severity index and the CRB-65 in cancer patients with community-acquired pneumonia. Int J Tuberc Lung Dis. 2009 Dec;13(12):1550-6.

Tavel JA; INSIGHT STALWART Study Group, Babiker A, Fox L, Gey D, Lopardo G, Markowitz N, Paton N, Wentworth D, Wyman N. Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: the STALWART study. PLoS One. 2010 Feb 23;5(2):e9334

Stamboulian D, Lopardo G, Lopez P, Cortes-Barbosa C, Valencia A, Bedell L, Karsten A, Dull PM Safety and immunogenicity of an investigational quadrivalent meningococcal CRM(197) conjugate vaccine, MenACWY-CRM, compared with licensed vaccines in adults in Latin America. Int J Infect Dis. 2010 Int J Infect Dis. 2010 Oct;14(10):e868-75

Bantar C, Curcio D, Jasovich A, Bagnulo H, Arango A, Bavestrello L, Famiglietti A, García P, Lopardo G, Losanovscky M, Martínez E, Pedreira W, Piñeyro L, Remolif C, Rossi F, Varón F Updated acute community-acquired pneumonia in adults: Guidelines for initial antimicrobial therapy based on local evidence from the South American Working Group (ConsenSur II). Rev Chilena Infectol. 2010 Jun;27 Suppl 1:S9-S38.

Alvarez C, Salazar R, Galindez J, Rangel F, Castaãeda ML, Lopardo G, Cuhna CA, Roldan Y, Sussman O, Gutierrez G, Cure-Bolt N, Seas C, Carcamo C, Castrillo M. Metabolic syndrome in HIV-infected patients receiving antiretroviral therapy in Latin America. Braz J Infect Dis. 2010 May-Jun;14(3):256-63.

Arnold FW, Brock GN, Peyrani P, Rodríguez EL, Díaz AA, Rossi P, Ramirez JA; CAPO authors Predictive accuracy of the pneumonia severity index vs CRB-65 for time to clinical stability: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study. Respir Med. 2010 Nov;104(11):1736-43.

Corey GR, Wilcox MH, Talbot GH, Thye D, Friedland D, Baculik T; CANVAS 1 investigators.

CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections. J Antimicrob Chemother. 2010 Nov;65 Suppl 4:iv41-51

Riquelme R, Jiménez P, Videla AJ, Lopez H, Chalmers J, Singanayagam A, Riquelme M, Peyrani P, Wiemken T, Arbo G, Benchetrit G, Rioseco ML, Ayesu K, Klotchko A, Marzoratti L, Raya M, Figueroa S, Saavedra F, Pryluka D, Inzunza C, Torres A, Alvare P, Fernandez P, Barros M, Gomez Y, Contreras C, Rello J, Bordon J, Feldman C, Arnold F, Nakamatsu R, Riquelme J, Blasi F, Aliberti S, Cosentini R, Lopardo G, Gnoni M, Welte T, Saad M, Guardiola J, Ramirez J.

Predicting mortality in hospitalized patients with 2009 H1N1 influenza pneumonia.

Dwyer DE; INSIGHT Influenza Study Group.

Vaccine. 2011 Jul 22;29 Suppl 2:B56-62.

Surveillance of illness associated with pandemic (H1N1) 2009 virus infection among adults using a global clinical site network approach: the INSIGHT FLU 002 and FLU 003 studies.

Lopardo G, Titanti P, Berdiñas V, Barcelona L, Curcio D. Antimicrobial stewardship program in a developing country: the epidemiological barrier. Rev Panam Salud Publica. 2011 Dec;30(6):667-8. No abstract available.

Markowitz N, Lopardo G, Wentworth D, Gey D, Babiker A, Fox L, Tavel J; STALWART Study Group.

Long-term effects of intermittent IL-2 in HIV infection: extended follow-up of the INSIGHT STALWART Study. PLoS One. 2012;7(10):e47506. doi: 10.1371/journal.pone.0047506. Epub 2012 Oct 17.

Lopardo G, Bissio E, Espinola L, Gallego P, Stambullian M, Gadano A. Fasting Increases Serum Concentrations of Bilirubin in Patients Receiving Atazanavir: Results from a Pilot Study. AIDS Res Hum Retroviruses. 2012 Oct 31. [Epub ahead of print]

Bissio E, Lopardo GD. Incidence of Hyperbilirubinemia and Jaundice Due to Atazanavir in a Cohort of Hispanic Patients. AIDS Res Hum Retroviruses. 2012 Nov 28. [Epub ahead of print] No abstract available.

Lopardo G, Calmaggi A, Clara L, Levy Hara G, Mykietiuk A, Pryluka D, Ruvinsky S, Vujacich C, Yahni D, Bogdanowicz E, Klein M, López Furst MJ, Pensotti C, Rial MJ, Scapellato P. [Consensus guidelines for the management of upper respiratory tract infections]. Medicina (B Aires). 2012;72(6):484-94. Spanish

Pryluka D, Lopardo G, Daciuk L, Stecher D, Bonvehi P. Severe acute respiratory disease in health-care workers during the influenza H1N1 pandemic in Argentina.J Infect Dev Ctries. 2013 Jan 15;7(1):36-40.

Davey RT Jr, Lynfield R, Dwyer DE, Losso MH, Cozzi-Lepri A, Wentworth D, Lane HC, Dewar R, Rupert A, Metcalf JA, Pett SL, Uyeki TM, Bruguera JM, Angus B, Cummins N, Lundgren J, Neaton JD; INSIGHT FLU 002 & 003 Study Groups. The association between serum biomarkers and disease outcome in influenza A(H1N1)pdm09 virus infection: results of two international observational cohort studies. PLoS One. 2013;8(2):e57121. doi: 10.1371/journal.pone.0057121. Epub 2013 Feb 27

Lopardo G, Pensotti C, Scapellato P, Caberlotto O, Calmaggi A, Clara L, Klein M, Levy Hara G, López Furst MJ, Mykietiuk A, Pryluka D, Rial MJ, Vujacich C, Yahni D. [Inter-society consensus for the management of respiratory infections: acute bronchitis and chronic obstructive pulmonary disease]. Medicina (B Aires). 2013;73(2):163-73. Spanish.

Saira K, Lin X, DePasse JV, Halpin R, Twaddle A, Stockwell T, Angus B, Cozzi-Lepri A, Delfino M, Dugan V, Dwyer DE, Freiberg M, Horban A, Losso M, Lynfield R, Wentworth DN, Holmes EC, Davey R, Wentworth DE, Ghedin E; INSIGHT FLU002 Study Group; INSIGHT FLU003 Study Group. Sequence analysis of in vivo defective interfering-like RNA of influenza A H1N1 pandemic virus. J Virol. 2013 Jul;87(14):8064-74. doi: 10.1128/JVI.00240-13. Epub 2013 May 15

Boyd MA, Kumarasamy N, Moore CL, Nwizu C, Losso MH, Mohapi L, Martin A, Kerr S, Sohn AH, Teppler H, Van de Steen O, Molina JM, Emery S, Cooper DA. SECOND-LINE Study Group . Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE): a randomised, open-label, non-inferiority study., Lancet. 2013 Jun 15;381(9883):2091-9. doi: 10.1016/S0140-6736(13)61164-2.

López Furst MJ, de Vedia L, Fernández S, Gardella N, Ganaha MC, Prieto S, Carbone E, Lista N, Rotryng F, Morera GI, Mollerach M, Stryjewski ME; Grupo de Estudio de Infecciones de Piel y Estructuras Relacionadas por Staphylococcus aureus meticilino-resistente de la Comunidad, Sociedad Argentina de Infectología. Prospective multicenter study of community-associated skin and skin structure infections due to methicillin-resistant Staphylococcus aureus in Buenos Aires, Argentina. PLoS One. 2013 Nov 20;8(11):e78303. doi: 10.1371/journal.pone.0078303. eCollection 2013

Lopardo G, Yahni D. On the role of groups C and G streptococci in acute pharyngitis. Medicina (B Aires). 2013;73(6):606. Spanish. No abstract available

Wiemken TL, Carrico RM, Klein SL, Jonsson CB, Peyrani P, Kelley RR, Aliberti S, Blasi F, Fernandez-Gonzalez R, Lopardo G, Ramirez JA; CAPO Investigators.

The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: Results from the Community-Acquired Pneumonia Organization (CAPO) international cohort study. Vaccine. 2014 Apr 17;32(19):2198-203. doi: 10.1016/j.vaccine.2014.02.048. Epub 2014 Mar 6

Borges AH, O'Connor JL, Phillips AN, Baker JV, Vjecha MJ, Losso MH, Klinker H, Lopardo G, Williams I, Lundgren JD; INSIGHT SMART Study Group; ESPRIT Study Group; SILCAAT Scientific Committee Factors associated with D-dimer levels in HIV-infected individuals. PLoS One. 2014 Mar 13;9(3):e90978. doi: 10.1371/journal.pone.0090978. eCollection 2014

Leda Guzzi, Gustavo Lopardo, Lidia Espinola, María Cecilia Niccodemi, Laura Barcelona, Julio Ramírez y grupo CAPO. Mortalidad en pacientes con neumonía provenientes de geriátrico: estudio caso-control. Rev Am Med Resp 2013;3 :133 -139

Nordell AD, McKenna M, Borges ÁH, Duprez D, Neuhaus J, Neaton JD; INSIGHT SMART, ESPRIT Study Groups; SILCAAT Scientific Committee. Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation. J Am Heart Assoc. 2014 May 28;3(3):e000844. doi: 10.1161/JAHA.114.000844.

Lynfield R, Davey R, Dwyer DE, Losso MH, Wentworth D, Cozzi-Lepri A, Herman-Lamin K, Cholewinska G, David D, Kuetter S, Ternesgen Z, Uyeki TM, Lane HC, Lundgren J, Neaton JD; INSIGHT Influenza Study Group. Outcomes of influenza A(H1N1)pdm09 virus infection: results from two international cohort studies. PLoS One. 2014 Jul 8;9(7):e101785. doi: 10.1371/journal.pone.0101785. eCollection 2014.

Lopardo G, Morfin-Otero R, Moran-Vazquez II, Noriega F, Zambrano B, Luxemburger C, Foglia G, Rivas EE. Epidemiology of Clostridium difficile: a hospital-based descriptive study in Argentina and Mexico. Braz J Infect Dis. 2014 Aug 29. pii: S1413-8670(14)00167-6. doi: 10.1016/j.bjid.2014.07.004. [Epub ahead of print]

PMID:25179510 [PubMed - as supplied by publisher]

INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group, Lundgren J, Babiker A, Gordin F, Emery S, Fätkenheuer G, Molina JM, Wood R, Neaton JD. Why START? Reflections that led to the conduct of this large long-term strategic HIV trial. HIV Med. 2015 Apr;16 Suppl 1:1-9. doi: 10.1111/hiv.12227. No abstract available.

Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L; D:A:D study group; Royal Free Hospital Clinic Cohort; INSIGHT study group; SMART study group; ESPRIT study group. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study. PLoS Med. 2015 Mar 31;12(3):e1001809. doi: 10.1371/journal.pmed.1001809. eCollection 2015

Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis. Boyd MA, Moore CL, Molina JM, Wood R, Madero JS, Wolff M, Ruxrungtham K, Losso M, Renjifo B, Teppler H, Kelleher AD, Amin J, Emery S, Cooper DA; SECOND-LINE study group. Lancet HIV. 2015 Feb;2(2):e42-51. doi: 10.1016/S2352-3018(14)00061-7. Epub 2015 Jan 20.

[Guidelines for management of community-acquired pneumonia in adults].

Lopardo G, Basombrío A, Clara L, Desse J, De Vedia L, Di Libero E, Gañete M, López Furst MJ, Mykietiuk A, Nemirovsky C, Osuna C, Pensotti C, Scapellato P. Medicina (B Aires). 2015;75(4):245-57.

Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.INSIGHT START Study Group, Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, Sharma S, Avihingsanon A, Cooper DA, Fätkenheuer G, Llibre JM, Molina JM, Munderi P, Schechter M, Wood R, Klingman KL, Collins S, Lane HC, Phillips AN, Neaton JD. N Engl J Med. 2015 Aug 27;373(9):795-807. doi: 10.1056/NEJMoa1506816. Epub 2015 Jul 20

BOOKS

Lopardo G. Home therapy in Infectious diseases. In: Stamboulian D. Infectología para la práctica diaria. Eds FUNCEI, Fundación del Centro de Estudios Infectológicos, Buenos Aires, 1995. 51-69.

Cassetti I, Lopardo G. y col. Infectología, capítulo 16. En: Sanguinetti CA y col. Semiología, Semiotecnia y Medicina Interna. 7( edición. Eds. López Libreros, Buenos Aires, 1998

Lopardo G. Diagnosis and Treatment of Uncomplicated Urinary Tract Infections. In Stamboulian D. Temas de Infectología Clínica. Eds. McGraw-Hill, Buenos Aires,2002.159-175.

Nacinovich F, Lopardo G, StamboulianD. Infecciones. In Trongé Jorge. Emergencias Cardiovasculares en el Geronte. Eds Cesarini Hnos, Buenos Aires, 2002.311-333..

Lopardo Gustavo. Enfermedades de transmisión sexual. En: Paganini Hugo R. Infectología Pediátrica, 1( edición Eds Científica Interamericana S.A.C.I., Buenos Aires, 2007: 466-475

Lopardo Gustavo. Hacia el control de la epidemia. En: Waldo H. Belloso, Esteban Martínez. La era del SIDA, 100 preguntas. 1ª ed. Buenos Aires: delhospital ediciones, 2013, páginas 98-106

EXPERIENCES IN CLINICAL INVESTIGATION

2001 Course “Metodología de la Investigación”, Academia Nacional de Medicina, including training in Good Clinical Practice.

2003 “Curso de formación de investigadores clínicos. Prof. Dr. José Tessler”, 145 hours, including training in Good Clinical Practice.

Co-Investigator in the study ´´ Zalcitavine in combination with zidovudine for the treatment of advanced HIV disease.´´ Protocol number M50002, 1994.

Co-Investigator in the study ´´Face III controlled double blinded randomized multinational study for the preventive therapy of latent tuberculosis in HIV positive individuals: isoniacid (300mglday per 12 months) vs. Rifabutine (300mglday per 3 months). 1995.

Co-Investigator in the study: ´´An international, multicenter, open-label, non-comparative trial of recombinant-methionyl human granulocyte colony stimulating factor (r-metHuG-CSF, filgrastim) for reversal of neutropenia in patients with HIV infection. 1993.

Co-Investigator in the study: Face II-III study, multicentric, non comparative, open label for the treatment with oral gatifloxacina for community adquired pneumonia. Protocol number A1420-003. 1997.

Principal Investigator in: A randomized, controlled, phase II trial comparing escalating doses of subcutaneous interleukin-2 plus antiretrovirals versus antiretrovirals alone in human immunodeficiency virus-infected patients with CD4+ cell count (350/mm3. National institute of Health. 1997.

Co-Investigator in the study: Face II-III study an open-label, multicenter study of clinafloxacin in the treatment of infective endocarditis. Parke Davis. 1998

Co-Investigator in the study phase IIIB/IV clinical trial protocol – a multiinvestigator comparative study of cefepime versus broad spectrum antibacterial therapy: empiric therapy in moderate and severe presumed bacterial infections. Bristol Myers Squibb. 2000

Principal Investigator in the study: ´´A prospective, multicenter, double-blinded, randomized, comparative study to evaluate the safety, tolerability, and efficacy of MK-0826 versus piperacillin/tazobactam in the treatment of complicated skin and skin structure infections in adults. Protocol number 016-01, MSD. 1999

Principal Investigator in the study: ´´A prospective, multicenter, double-blinded, randomized, comparative study to evaluate the safety, tolerability, and efficacy of MK-0826 versus ceftriaxone in the treatment of severe community-acquired pneumonia in adults.. Protocol number 018-00, MSD. 1999

Principal Investigator in the study: ´´A prospective, multicenter, double-blinded, randomized, comparative study to evaluate the safety, tolerability, and efficacy of MK-0826 versus cefepime in the treatment of hospital-acquired pneumonia in adults.. Protocol number 025-00 MSD. 1999-2001

Principal Investigator in. A randomized, double-blind, multicenter, comparative, phase III study of 5-day oral BMS-284756 versus oral amoxicillin/clavulanate in the treatment of mild to moderate community acquired pneumonia. Phase III, Bristol Myers Squibb. 2001

Principal Investigator in the study: Surveillance of resistance in non complicated urinary tract infecton pathogens. Sponsored by VIGIA program. Ministry of Public Health and Banco Interamericano de Desarrollo (BID). 2001.

Principal Investigator in the study ´´A phase III multicenter randomized study of the biological and clinical efficacy of subcutaneous recombinant, human interleukin-2 in HIV-infected patients with low CD4 counts under active antiretroviral therapy (SILCAAT). Chiron. 2000, ongoing.

Principal Investigator in the study ¨A randomized, open-label, phase III, international study of subcutaneous recombinant IL-2 (Proleukin) in patients with HIV-1 infection and CD4 cell count (300/mm3: evaluation of subcutaneous proleukin in a randomized international trial (ESPRIT). National Institute of Health. 2000-2008

Principal Investigator in the study “Assessment of resistance in urinary tract pathogens causing uncomplicated urinary tract infections”. Sponsored by VIGI+A –Ministry of Public Health, Argentina. 2001

Principal Investigator in the study ´´A phase III multicenter randomized study of the biological and clinical efficacy of subcutaneous recombinant, human interleukin-2 in HIV-infected patients with low CD4 counts under active antiretroviral therapy (SILCAAT). Chiron. 2000-2008.

Principal Investigator in the study “Phase III Multicenter Study to confirm safety and efficacy of IV doripenem to treat complicated urinary tract infections and pyelonephritis” , 2004-2005

Principal Investigator in the study “Dobre blinded, multicenter, randomized, phase III study to compare safety and efficacy of IV doripenem in treatment of complicated abdominal infections”. Peninsula, 2004-2005

Co-Investigador in the study “Manejo de lipodistrofia mediante un programa único de nutrición y ejercicio supervisado en pacientes con infección por HIV” (Estudio LUNES).

Co-Investigator in the study “Strategies for Management of Anti-Retroviral Therapy (SMART) sponsored by the Divisssion of AIDS of the National Institute of Allergy and Infectious Diseases, National Institutes of Health, 2004-2006

Principal Investigator in the study -RO 4908463 “Un estudio de prueba de concepto, de grupos paralelos, controlado por comparador activo, doble ciego, randomizado, prospectivo, Fase II en pacientes adultos con neumonía adquirida en la comunidad que requieren hospitalización, sin evidencia alguna de Legionella.” (CAPTURE) Roche, 2005

Principal Investigator for Argentina and member of the International steering committee for the study; “A Randomized, Open-Label, International Study of Subcutaneous Recombinant Interleukin-2 (rIL-2, Aldesleukin) with and without Concomitant Antiretroviral Therapy in Patients with HIV-1 Infection and CD4+ Cell Counts ≥ 300/mm3: Study of Aldesleukin with and without Antiretroviral Therapy (ESPRIT 002: STALWART), ongoing.

Principal Investigator “Multicenter, Randomized phase III Study to compare Safety and Efficacy of intravenous doripenem with intravenous piperacillin-tazobactam in patients with hospital-acquired pneumonia.”. DORI 09. Janssen Cilag, 2006

Principal Investigator “Multicenter, Randomized, doublé blind phase III Study to compare safety and efficacy of intravenous ceftarolina with intravenous vancomycin-aztreonam in patients with complicated soft and skin tissue infections”. Janssen-Cilag P903-06, 2007

Subinvestigador in Multicenter, Randomized blind phase III study to compare immunogenicity And safety of antimeningococcal conjugated vaccinea ACWY-Novartis with MenactraTM and Menomune®. Protocol study V59P17. Novartis Vaccines & Diagnostics, Inc. 2007

Principal Investigator “Multicenter, Randomized, Double Blind, phase III Study to compare safety and efficacy of intravenous ceftaroline with intravenous ceftriaxone in patients with community-acquired pneumonia. Janssen-Cilag P903-08, 2008

Principal Investigator in the Study START Strategic Timing of Anti-Retroviral Treatment. National Institute of Health. 2009-ongoing

Principal Investigator “Descriptive Eídemiology of Clostridium difficile in Latin America (CDI02) Started in 2010-ongoing Investigator Initiative Research

Principal Investigator in the study “International Observational Study to Characterize Adults with Influenza A-H1N1 Pandemic (H1N1v) INSIGHT Outpatient Study H1N1 (FLU002), sponsored by the University of Minnesota, the National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA (NIAID), ongoing.

Principal Investigator in the study "International Observational Study to Characterize Hospitalized Adults with Complications of Influenza A-H1N1 Pandemic (H1N1v)" Inpatient Study INSIGHT H1N1 (FLU003), sponsored by the University of Minnesota, the National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA (NIAID), ongoing.

Principal Investigator in the epidemiological study to assess the incidence of diarrhea caused by Clostriidium difficile in a general hospital, sponsored by SANOFI-PASTEUR, September 2010 - August 2011

Principal Investigator in the study IRC 003: Un estudio doble ciego, aleatorizado, de fase 2 que compara la eficacia, seguridad y tolerabilidad deentre la combinación de antivirales (amantadina, ribavirina, oseltamivir) cony oseltamivir para el tratamiento de la influenza en adultos con riesgo de complicaciones, patrocinado por los Institutos Nacionales de la Salud de los Estados Unidos (NIH). Hospital Bernardo Houssay, 2013 y FUNCEI 2014

Principal Investigator in the study IRC 004: Un estudio doble ciego, aleatorizado que compara oseltamivir con placebo para el tratamiento de la influenza en adultos con bajo riesgo”, patrocinado por los Institutos Nacionales de la Salud de los Estados Unidos (NIH). Hospital Bernardo Houssay, 2013

Principal Investigator in the study multicéntrico, doble ciego, aleatorizado, de fase 3 para comparar la eficacia y la seguridad de CXA-201 intravenoso con las de meropenem en infecciones intraabdominales complicadas” patrocinado por CUBIST, Hospital Bernardo Houssay, 2013

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download